ADVERSE REACTIONS
In rare cases, anaphylaxis has been reported after the first dose. Several cases of hypersensitivity reactions including urticaria have also been reported. However, the most frequent adverse reactions were nausea and/or vomiting in approximately 3%, abdominal pain in 1.2%, pruritus in 1.5%, and the following in less than 1% of the patients: headache, dizziness, somnolence, fever and chills, photophobia, diarrhea, gynecomastia, impotence, thrombocytopenia, leukopenia, hemolytic anemia, and bulging fontanelles. Oligospermia has been reported in investigational studies with the drug at dosages above those currently approved. Oligospermia has not been reported at dosages up to 400 mg daily, however sperm counts have been obtained infrequently in patients treated with these dosages. Most of these reactions were mild and transient and rarely required discontinuation of NIZORAL® (ketoconazole) Tablets. In contrast, the rare occurrences of hepatic dysfunction require special attention (see WARNINGS section).
In worldwide postmarketing experience with NIZORAL® Tablets there have been rare reports of alopecia, paresthesia, and signs of increased intracranial pressure including bulging fontanelles and papilledema. Hypertriglyceridemia has also been reported but a causal association with NIZORAL® Tablets is uncertain.
Neuropsychiatric disturbances, including suicidal tendencies and severe depression, have occurred rarely in patients using NIZORAL® Tablets.
Ventricular dysrhythmias (prolonged QT intervals) have occurred with the concomitant use of terfenadine with ketoconazole tablets. (See BOX WARNING, CONTRAINDICATIONS, and WARNINGS sections.) Data suggest that coadministration of ketoconazole tablets and cisapride can result in prolongation of the QT interval and has rarely been associated with ventricular arrhythmias. (See CONTRAINDICATIONS, WARNINGS, and PRECAUTIONS sections.)
|
REPORTS OF SUSPECTED NIZORAL SIDE EFFECTS / ADVERSE REACTIONS
Below is a sample of reports where side effects / adverse reactions may be related to Nizoral. The information is not vetted and should not be considered as verified clinical evidence.
Possible Nizoral side effects / adverse reactions in 52 year old female
Reported by a pharmacist from China on 2011-10-17
Patient: 52 year old female
Reactions: Cholecystitis, Intentional Drug Misuse, Hepatitis, Gastritis
Adverse event resulted in: hospitalization
Suspect drug(s):
Nizoral
Dosage: 26-jul, first box
Administration route: Oral
Nizoral
Dosage: 2 boxes in aug (year unspecified)
Administration route: Oral
Indication: Onychomycosis
Possible Nizoral side effects / adverse reactions in 59 year old male
Reported by a consumer/non-health professional from Korea, Republic of on 2011-11-21
Patient: 59 year old male
Reactions: Hypokinesia, Skin Exfoliation, Pyrexia, Rash
Suspect drug(s):
Nizoral
Possible Nizoral side effects / adverse reactions in 41 year old female
Reported by a consumer/non-health professional from United States on 2012-01-24
Patient: 41 year old female
Reactions: Cellulitis, Drug Ineffective
Suspect drug(s):
Armodafinil
Indication: Product Used FOR Unknown Indication
Nizoral
Indication: Product Used FOR Unknown Indication
|